Inovalon. Client Congress. October 1-3, 2017 THE RITZ-CARLTON WASHINGTON, D.C.

Transcription

1 Inovalon Client Congress 2017 October 1-3, 2017 THE RITZ-CARLTON WASHINGTON, D.C.

2 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. SUNDAY, OCTOBER 1 7:00 pm - 10:00 pm Welcome Reception 101 Constitution Please join us as we welcome you to Washington, D.C., and Client Congress 2017 on Sunday evening, October 1 at the Rooftop of 101 Constitution offering unobstructed panoramic views of the Capitol and the National Mall brilliantly lit against the evening sky. MONDAY, OCTOBER 2 Achieving Performance Goals with Advanced Analytics Technology Innovations Driving Impact Data-Driven Insights Improving Quality Outcomes & Economics 8:00a - 9:40a Product Roundtables 10:00a - 10:20a Keynote: Keith Dunleavy, M.D., Chief Executive Officer and Chairman of the Board, Inovalon 10:20a - 11:00a 11:00a - 11:40a Keynote: Congresswoman Allyson Y. Schwartz, President and Chief Executive Officer, Better Medicare Alliance Keynote: Thomas Moriarty, Executive Vice President, Chief Policy and External Affairs Officer and General Counsel, CVS Health 11:40a - 12:40p Lunch and Networking 12:45p - 1:25p 1:25p - 2:05p Keynote: Farzad Mostashari, M.D., ScM, CEO and Co-Founder, Aledade, Inc.; Former National Coordinator for Health Information Technology Keynote: Derek Rapp, President and Chief Executive Officer, Juvenile Diabetes Research Foundation (JDRF) 2:05p - 2:30p Break 2:30p - 3:20p Empowering Physicians with Data-Driven Insights Translating Data Insights into Value MACRA MIPS & APMs: Are You Ready for the New Era of Physician Payment? 3:20p - 4:20p Navigating the Reimbursement Payment Models Advancing Treatment and Improving Outcomes Driving Greater Outcomes through Cloud-Based Processing & Analytics 4:20p - 5:10p Transitioning to the Encounter Data System: Impact and Implications What s Next? Key Policy Trends in the U.S. Healthcare System Quality Measure Auditor Insight: What s New and What s Next in the World of Quality Reporting 7:00p - 10:00p Client Appreciation Dinner: Smithsonian National Museum of American History

3 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. 8:00 am - 9:40 am Product Roundtables 10:00 am - 10:20 am Welcome Keynote Address Keith Dunleavy, M.D., Chief Executive Officer and Chairman of the Board, Inovalon 10:20 am - 11:00 am Keynote: Congresswoman Allyson Y. Schwartz Congresswoman Allyson Y. Schwartz, President and Chief Executive Officer, Better Medicare Alliance Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour 11:00 am - 11:40 am Keynote: Thomas Moriarty Thomas Moriarty, Executive Vice President, Chief Policy and External Affairs Officer and General Counsel, CVS Health Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour 12:45 pm - 1:25 pm Keynote: Farzad Mostashari, M.D. Farzad Mostashari, M.D., ScM, CEO and Co-Founder, Aledade, Inc.; Former National Coordinator for Health Information Technology Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour 1:25 pm - 2:05 pm Keynote: Derek Rapp Derek Rapp, President and Chief Executive Officer, Juvenile Diabetes Research Foundation (JDRF) Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour

4 2:30 pm - 3:20 pm Empowering Physicians with Data-Driven Insights Moderated by Paige Kilian, M.D., Vice President, Clinical Analytics, Inovalon, joined by the following panelists: Kimberly Swanson, Director, Quality, Network Health Kris Trafton, Director, Risk Adjustment, Geisinger Health Plan Jennifer Zucchero, Manager, Risk Revenue, Gateway To ensure the right care is delivered to the right patient at the right time, physicians and payers need patient-specific insights, delivered in real time at the point of care. Learn how improved transparency between physicians and payers can drive meaningful improvements in quality measurement and economic performance as our panelists discuss the importance of bringing together disparate data sources to enable highly granular, patient-level insights in real time for successful value-based care arrangements. Translating Data Insights into Value Moderated by Sarah Donovan, Vice President, Avalere, joined by the following panelists: Kate Eshelman, M.D., Vice President, Clinical Enterprise Tools, Inovalon Kurt Smith, Vice President, Data Science Technology Solutions, Medtronic Stephen Sander, Director, Health Economics and Outcomes Research, Boehringer Ingelheim Pharmaceuticals April Todd, Vice President, Avalere Industry-wide discussion around value-based arrangements as a means to drive value in healthcare has been increasing, yet emphasis continues to be placed on how challenging it is to implement. In this session, experts will share insights from their experiences with value-based agreements and discuss how data-driven analytics are being leveraged to break down barriers and accelerate the shift from volume to value. Attendees will learn how data is essential to support successful value propositions, how alignment can best be achieved between entities, and what s in store for the future. MACRA MIPS & APMs: Are You Ready for the New Era of Physician Payment? Fred Bentley, Vice President, Avalere Robert Nesse, M.D., Senior Medical Advisor, Healthcare Policy and Payment Reform, Mayo Clinic Angel Oddo, Senior Vice President, Quality Products & Solutions, Inovalon With the first year under the Medicare Access and CHIP Reauthorization Act s (MACRA) mandatory Quality Payment Program (QPP) nearing completion and submission deadlines for 2017 performance

5 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. data just around the corner, providers across the care continuum remain at varying levels of readiness for this new era of physician payment. In this session, our subject matter experts will take a look back at the first year of MACRA implementation and its impact on providers and other industry stakeholders and look ahead to what s to come next year and beyond. Join the discussion to learn how data-driven analytics can support quality reporting requirements under the QPP by offering a deeper understanding of expected performance and opportunities for improvement, as well as helping identify and evaluate the impact of improving performance on key measures to inform goals. 3:20 pm - 4:20 pm Navigating the Reimbursement Payment Models Moderated by Matt Caminiti, Director, Product Execution, Inovalon, joined by the following panelists: Jim Clement, Associate Vice President, Products & Services, Inovalon Gabe Medley, Vice President, Quality, Risk Revenue, Gateway Health Organizations participating in government-sponsored healthcare programs must understand the reimbursement systems administered for their populations or they compromise financial performance and hinder care quality. Join our industry experts to learn the complex requirements of documentation and submission, the differences between Medicare Advantage, managed Medicaid, and Commercial ACA payment models, and best practices to effectively and compliantly navigate them. The expert panelists will also address how the evolving healthcare landscape may impact the predictive accuracy of these models. Advancing Treatment and Improving Outcomes Lisa Bo Feng, Senior Director of Policy & Advocacy, Cystic Fibrosis Foundation David Harrison, Director, Global Health Economics, Amgen Tanya Shah, Assistant Vice President, The Commonwealth Fund Christie Teigland, Ph.D., Vice President, Avalere Given the complicated nature of outcomes improvement and the numerous requirements for building and maintaining an effective, continuous program with sustained outcomes, it s no wonder health systems are overwhelmed. Successfully tracking and sustaining quality improvement in healthcare is a tall order to fill. In order to provide the highest level of care to the right patients at the lowest cost, health plans and providers need to develop targeted approaches based on individual member characteristics, which requires the support of evidence-based and data-driven analytics. Take a journey with industry leaders and experts through three use cases as they analyze treatment patterns and outcomes for Cystic Fibrosis patients, evaluate healthcare utilization and spending patterns of high-cost, high-need Medicare Advantage members and explore the use of cardiologist care by gender and other social risk factors.

6 Driving Greater Outcomes through Cloud-Based Processing & Analytics Neeloy Bhattacharyya, Technology Strategist, Dell EMC Courtney Breece, Senior Director, Product Development, Inovalon Tom Laughlin, Senior Director, Technology, Inovalon With organizations across the healthcare continuum increasingly focusing on care quality, the ability to leverage cloud-based processing technology and analytics can have a significant impact on supporting the achievement of quality performance and business goals. By exploring real-world applications of accelerated, transaction-based processing and analytic technology solutions, this session will offer insight into how healthcare organizations are overcoming data challenges to better capture, process and analyze patient data and improve quality performance. 4:20 pm - 5:10 pm Transitioning to the Encounter Data System: Impact and Implications Moderated by Sean Creighton, Vice President, Avalere, joined by the following panelists: Arati Swadi, Senior Director, Product Execution, Inovalon Christie Teigland, Ph.D., Vice President, Avalere Cynthia Tudor, Ph.D., Former Deputy Center Director, Centers for Medicare & Medicaid Services (CMS) As CMS is transitioning the calculation of Medicare Advantage (MA) plan risk scores from the Risk Adjustment Processing System (RAPS) to the Encounter Data System (EDS), this timely session will provide real-world insight that puts in perspective how the shift from a RAPS-based risk adjustment factor (RAF) to one that is calibrated using full encounter data affects payment rates for the industry. This analysis is based on the findings of research collaboration between Inovalon, Avalere and industry partners that examined the revenue neutrality of the change in approach. What s Next? Key Policy Trends in the U.S. Healthcare System Elizabeth Carpenter, Senior Vice President, Avalere Caroline Pearson, Senior Vice President, Avalere The healthcare industry is on the front lines of major changes in clinical standards, technology and policy all affecting how medicine is practiced, and in turn, the nation s health. To effectively manage this transformation, healthcare leaders must be aligned to successfully navigate these unchartered industry dynamics to ensure program performance that drives better patient outcomes. In this session, industry experts will discuss key market changes that will impact how plans, providers and innovators operate in the next 5 years and beyond. Attendees will learn the potential changes to the Affordable Care Act and the effect on future healthcare evolution; new initiatives to restructure

7 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. entitlement programs and the impact on your business; increasing trends and focus to encourage drug competition; and efforts to promote value-based payment and strategies to succeed through the transformation. Quality Measure Auditor Insight: What s New and What s Next in the World of Quality Reporting Moderated by Bill Carden, Senior Director, Quality Spectrum, Inovalon, joined by the following panelists: Tina Kind, Managing Partner, DTS Group Paul Mertel, Ph.D., Senior Vice President, HEDIS Development, HealthcareData Company, LLC Bob Oakleaf, Principal and Chief Executive Officer, Attest Healthcare Advisors From health plans to hospitals, post-acute care facilities to physicians the range and variety of healthcare organizations required to participate in quality reporting programs continues to grow. Alongside this evolving system aimed at ensuring patient care quality and value in all areas of healthcare, one thing remains the same the need for comprehensive data and reporting to ensure timely and accurate reimbursement. In this highly-anticipated session, experienced auditors from Attest Health Care Advisors, the HealthcareData Company and the DTS Group will explore what s new and what s next for healthcare payers and providers in the world of quality reporting. Attendees will gain insight into what s in store for 2018 and strategies and best practices to embark upon the upcoming quality reporting season. 7:00 pm - 10:00 pm Client Appreciation Dinner at Smithsonian National Museum of American History The National Museum of American History collects and preserves more than 3 million artifacts all true national treasures, everything from the original Star-Spangled Banner and Abraham Lincoln s top hat to Dizzy Gillespie s angled trumpet and Dorothy s ruby slippers from The Wizard of Oz. Join us for an evening engulfed by the fascinating mosaic of American life that comprise the single greatest collection of American history.

8 TUESDAY, OCTOBER 3 Achieving Performance Goals with Advanced Analytics Technology Innovations Driving Impact Data-Driven Insights Improving Quality Outcomes & Economics 8:00a - 9:40a Product Roundtables 10:00a - 10:30a Keynote: Dan Mendelson, President, Avalere 10:30a - 11:10a 11:10a - 11:50a Keynote: Rob Califf, M.D., Former Commissioner, U.S. Food and Drug Administration; Vice Chancellor, Health Data Science, Duke University; Advisor, Verily [formerly Google Life Sciences] Keynote: Shantanu Agrawal, M.D., President and Chief Executive Officer, National Quality Forum (NQF) 11:50a - 1:00p Lunch and Networking 1:00p - 1:50p Driving a Successful Virtual Care Strategy: Exploring an Innovation to Adoption Framework Speed to Value: How Data Drives Clinical Insights Filling the Gap: Developing Meaningful Quality Measures to Drive Improvements in Health Care Delivery 1:50p - 2:40p Data Visualization: Unlocking Where You ve Been, Where You Are, Where You Need to Go and How to Get There Leveraging the MORE 2 Registry Including Medicare FFS QE Data to Advance Healthcare Innovations Drug Pricing Policy: A Look Over the Horizon 8:00 am - 9:40 am Product Roundtables 10:00 am - 10:30 am Keynote Address: Dan Mendelson Dan Mendelson, President, Avalere Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour 10:30 am - 11:10 am Keynote Address: Rob Califf, M.D. Rob Califf, M.D., Former Commissioner, U.S. Food and Drug Administration; Vice Chancellor, Health Data Science, Duke University; Advisor, Verily formerly Google Life Sciences

9 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour 11:10 am - 11:50 am Keynote Address: Shantanu Agrawal, M.D. Shantanu Agrawal, M.D., President and Chief Executive Officer, National Quality Forum (NQF) Moderated by Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation; On-Air Health Policy Analyst, PBS NewsHour 1:00 pm - 1:50 pm Driving a Successful Virtual Care Strategy: Exploring an Innovation to Adoption Framework Moderated by Katherine Steinberg, Vice President, Avalere, joined by the following panelists: Sajid Ahmed, Chief Information and Innovation Officer, Martin Luther King, Jr. Community Hospital Lisa Altman, M.D., Chief, Healthcare Transformation and Innovation, Veterans Health Administration Ronald Dixon, M.D., Medical Director, Massachusetts General Hospital Gloria Zaionz, Emerging Technology Guru, Innovative Learning Network Virtual Care is far more than a new means of visiting the doctor. It s the gateway to a new system of coordinated care platforms that leverages the expertise of people with advances in technology. As platforms become ever more sophisticated, while delivering better health outcomes at lower costs, they will fundamentally reshape the delivery of U.S. healthcare. With virtual care entering a phase of accelerating growth with a number of regulatory indicators progressing adoption, such as FDA approval of remote diagnostic tools; the rapid evolution of Virtual Care platforms focused on managing chronic conditions as well as achieving specific patient outcomes; the expansion of Virtual Care services offered by private and government operated healthcare systems; and new directto-consumer initiatives, industry experts will discuss how a virtual care strategy will improve care coordination customized to meet patient needs, provide data-driven insights and patient-specific analytics to drive meaningful impact in your patient population and continue to advance technology innovation dedicated to improving quality outcomes.

10 Speed to Value: How Data Drives Clinical Insights Moderated by Eric Sullivan, Senior Vice President, Innovation & Data Strategies, Inovalon, joined by the following panelists: Kenyon Crowley, Deputy Director, Center for Health Information and Decision Systems, Robert H. Smith School of Business, University of Maryland Mariann Yeager, Chief Executive Officer, The Sequoia Project Harnessing data-driven insights to drive greater effectiveness and care quality is one of the highest priorities of healthcare organizations today. The implementation of an effective data strategy represents one of the cornerstones of better care, as well as greater operational efficiency and patient-specific insights to support data-driven clinical encounters. Listen as our experts discuss how a strategically developed approach that efficiently aggregates and processes information from diverse sources utilizing advanced technologies, such as Natural Language Processing (NLP), provides insights and a comprehensive, 360-degree patient view. Filling the Gap: Developing Meaningful Quality Measures to Drive Improvements in Health Care Delivery Moderated by Kristi Mitchell, Senior Vice President, Avalere, joined by the following panelists: Mary Barton, M.D., Vice President, Performance Measurement, National Committee for Quality Assurance (NCQA) Laura Cranston, RPh, President, Pharmacy Quality Alliance (PQA) Patrick Donnelly, Director & General Manager, Quality Spectrum, Inovalon With increasing diversity in the number and type of quality reporting programs aiming to accurately measure the quality of care provided to healthcare beneficiaries in the United States, the need for meaningful, quality measures capable of driving real improvements in healthcare delivery has never been so important. In this session, industry experts will explore key quality measure development initiatives currently underway, including the rise of electronic clinical quality measures (ecqms), efforts to increase innovation and collaboration in the quality measure development process, how to identify and address priority gap areas and specialties and develop measures with multi-payer applicability. 1:50 pm - 2:40 pm Data Visualization: Unlocking Where You ve Been, Where You Are, Where You Need to Go and How to Get There Moderated by Kris Volrath, Vice President of Platform Design and Operationalization, Inovalon, joined by the following panelists: Laura Campbell, Director, Quality Medical Services, Piedmont Community Health Plan Brianna Frost, Director, Enterprise Analytical Solutions, Inovalon

11 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. Terri Kitchen, Executive Director, Enterprise Quality & Accreditation, Blue Cross Blue Shield of Illinois Ron Purisima, Director, Quality Improvement, Gateway Payers and providers recognize the importance of transparency and the need for an intuitive, flexible interface with cutting-edge visualization and customization capabilities. Learn how healthcare organizations are gaining a deeper and more efficient understanding of their performance to enable informed decision making, leading to improved quality gap closure and economic performance. Join industry experts as they showcase successful business intelligence initiatives driving improvement across various programs, such as membership trends, comparative population analytics, provider performance, outcomes-based contracting success, medical and pharmacy outcomes and more. Leveraging the MORE 2 Registry Including Medicare FFS QE Data to Advance Healthcare Innovations Eric Sullivan, Senior Vice President, Innovation & Data Strategies, Inovalon April Todd, Senior Vice President, Avalere With one of the largest proprietary commercial datasets available in the country, with more than 230 million unique patients and nearly 30 billion medical events, Inovalon s data is unlocking meaningful improvements throughout the healthcare landscape. Fueling the Inovalon ONE Platform with robust benchmarking and comparative measures, the MORE² Registry is also providing industry-leading insights in real-time to drive impact wherever it is analytically identified best to intervene. Join our experts as they discuss real-world use cases showcasing the ability of Inovalon s expanded datasets to provide its partners with an expanded look into all parts of Medicare to maximize network performance, evaluate and support risk-based payment arrangements including episodic bundling and ACO shared savings, actively managing patient care, and a variety of other mission-critical operations. As the healthcare industry continues to transition towards valuebased care, this data will help providers, health systems, health plans and others better manage their risk-based program performance and inform care management activities to support better patient outcomes. Drug Pricing Policy: A Look Over the Horizon Moderated by Tom Kraus, Senior Vice President, Avalere, joined by the following panelists: Donna Altenpohl, Senior Director, Strategic Customer Group, Johnson & Johnson Sean Creehan, President, creehan and company Rujul Desai, Vice President, Avalere Consumers rate drug prices as their primary concern in healthcare amplified by the growth in spending on prescription drugs in Medicare and Medicaid. Policymakers, state governments and private organizations have proposed policies to address drug prices that each carry their own set of implications. Join in as experts discuss potential drug pricing policy changes that seek to increase transparency within the healthcare continuum, promote competition and market-based solutions and reforms to Medicaid and public program spending.

12 KEYNOTE SPEAKERS Keith R. Dunleavy, M.D., Chief Executive Officer and Chairman of the Board, Inovalon Dr. Dunleavy has served as Inovalon s Chief Executive Officer since his organization of the company s predecessor companies in 1998, as Chairman of the board of directors since the creation of the board in 2006, and as President from the Company s foundation until May of Dr. Dunleavy is responsible for the overall execution of the company s business plan, strategic relationships, and the identification and realization of company product strategy and vision. During his tenure at Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Driven by a vision of data s ability to drive insight and improvement in healthcare, Dr. Dunleavy has led Inovalon from its origins to its current industryleading position leveraging advanced, cloud-based platforms which are informed by data pertaining to more than 858,000 physicians, 377,000 clinical facilities, and 230 million Americans, and nearly 30 billion medical events providing a powerful platform that enables high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. Dr. Dunleavy received a Bachelor s degree in Biology modified with Engineering with High Honors from Dartmouth College where his studies and work focused upon the neurosciences, computer sciences and electrical engineering with his honors thesis focused on the computer simulation of artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced and was Board Certified in Internal Medicine. He serves as a Director on the Dartmouth Medical School Board of Overseers, has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, and has presented his work and materials at multiple national and international conferences.

13 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. CONFERENCE MODERATOR Susan Dentzer, Chief Executive Officer, The Network for Excellence in Health Innovation Susan Dentzer is CEO at Network for Excellence in Health Innovation. In this role, she works closely with foundation leaders to carry out the organizational mission of improving the health and healthcare of all Americans. One of the nation s most respected health and health policy thought leaders and journalists, she is also an on-air analyst on health issues on the PBS NewsHour. From 2008 to April 2013, she was the editor-in-chief of Health Affairs, the nation s leading peer-reviewed journal of health policy, and led the transformation of that journal from a bimonthly academic publication into a highly topical publication and web site with more than 120 million page views annually. From 1998 to 2008, she led the PBS NewsHour s health unit as on-air health correspondent, and was the recipient of numerous honors and awards. Ms. Dentzer is an elected member of the Institute of Medicine and the Council on Foreign Relations, and a public member of the board of directors of the American Board of Medical Specialties, a non-profit organization overseeing 24 approved medical specialty boards that set standards for board certification for the nation s physicians. She is also a member of the Board of Overseers of the International Rescue Committee, a humanitarian organization providing relief to refugees and displaced persons around the world. She chairs the IRC board s Program Committee, which oversees the organization s activities in resettling refugees in the United States and dealing with refugees and displaced persons in roughly 25 countries. A Nieman Fellow at Harvard University in , Ms. Dentzer is a graduate of Dartmouth and holder of an honorary master of arts from the institution. She is also a Dartmouth trustee emerita, and was the only woman to date to chair the Dartmouth Board of Trustees, from 2001 to She has served on the Board of Overseers of Dartmouth Medical School since A widely admired communicator, Ms. Dentzer is a frequent speaker before a wide variety of health care and other groups, and a frequent commentator on such National Public Radio shows as the Diane Rehm Show and This American Life. She and her husband have three children and live in the Washington, D.C. area.

14 KEYNOTE SPEAKERS Congresswoman Allyson Y. Schwartz, President and Chief Executive Officer, Better Medicare Alliance Allyson Y. Schwartz, a former member of the U.S. House of Representatives from Pennsylvania who served from , is a nationally recognized leader on health care issues. Throughout her professional life she has worked on issues such as affordability, prevention, primary care, coordinated care and increased access to coverage. Having worked as a health service executive, Ms. Schwartz was elected to the Pennsylvania State Senate in 1990, serving 14 years until her election to Congress. In the state Senate, she was the driving force behind Pennsylvania s CHIP program, which was a model for the federal CHIP program five years later. In Congress, Ms. Schwartz was appointed to the powerful Ways and Means committee in her second term and served as a senior member of the Budget Committee. In both capacities, she was a strong advocate for Medicare. She was the leader in Congress on physician payment reform to encourage value over volume, supported research, innovation and use of technology to improve quality, efficiency and contain costs. Ms. Schwartz was instrumental in the passage of landmark health reform legislation, authoring key provisions such as the ban on pre-existing condition exclusions for children and increased access to primary care. She is a Distinguished Policy Fellow at the University of Pennsylvania s Leonard Davis Institute of Health Economics, Visiting Fellow at the Penn Wharton Public Policy Initiative, Senior Fellow for Health Policy at the Center for American Progress and Co-Chair of the Bipartisan Policy Center Health and Housing Task Force. Ms. Schwartz earned a B.A. from Simmons College and a Master of Social Service (MSS) from Bryn Mawr College. She is married, has two grown sons, a daughter-in-law, and a 2 ½-year-old granddaughter.

15 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. KEYNOTE SPEAKERS Thomas Moriarty, Executive Vice President, Chief Policy and External Affairs Officer and General Counsel, CVS Health Thomas Moriarty is Executive Vice President, Chief Policy and External Affairs Officer and General Counsel for CVS Health, a position he has held since March In this role, Mr. Moriarty leads the company s external affairs programs, including the policy, government and public affairs, corporate communications and legal and regulatory teams. Mr. Moriarty brings his past experience of impacting and shaping national and state-specific public policy to his current responsibilities. He is keenly focused on promoting the company s role in reshaping a health care industry that is more accessible and affordable, and that delivers better outcomes for patients. Mr. Moriarty joined CVS Health in 2012 and since that time has held several senior roles, including General Counsel, Chief Strategy Officer, and chairman of Red Oak Sourcing, Inc. the global generics sourcing venture CVS Health formed with Cardinal Health. Prior to CVS Health, Mr. Moriarty most recently served as General Counsel at Celgene, a biopharmaceutical company, where he was responsible for global legal strategy and served on the company s management committee. Prior to that, he worked for 12 years at Medco Health Solutions where he served as General Counsel, Corporate Secretary and President of Global Pharmaceutical Strategies. He began his career at the law firm of Mudge Rose Guthrie Alexander and Ferdon in New York. Mr. Moriarty received his law degree from the University of Virginia School of Law and his undergraduate degree from Lafayette College.

16 KEYNOTE SPEAKERS Farzad Mostashari, M.D., ScM, Chief Executive Officer and Co-Founder, Aledade, Inc.; Former National Coordinator for Health Information Technology Dr. Farzad Mostashari is the CEO of Aledade, a start-up he co-founded aimed at helping primary care doctors form accountable care organizations (ACOs). Dr. Mostashari served from as the national coordinator for health information technology where he coordinated U.S. efforts to build a health information technology infrastructure for healthcare reform and consumer empowerment. During his tenure at the Office of the National Coordinator, including his two years as principal deputy, he led the implementation of the Health IT for Economic and Clinical Health (HITECH) Act including the design, development and monitoring of the EHR Certification Program (including interoperability standards), the $800M Regional Health IT Extension Program (with 140,000 primary care providers, the largest medical technical assistance program in US history), the Beacon Communities program and collaborated with the Centers for Medicare and Medicaid Services on the design and implementation of the Meaningful Use Incentive Program (garnering participation of >85% of eligible hospitals, and >74% of eligible professionals nationwide), in addition to programs for health information exchange, health IT workforce, research and privacy and security. This period saw a dramatic increase in adoption of Electronic Health Records (EHRs) from 9 to 44% among hospitals, and 17 to 40% among outpatient providers (latest data as of mid-2012). Under his leadership, the agency was recognized as one of the top 25 Innovations in Government by the Harvard Kennedy School of Government in Previously, Dr. Mostashari served at the New York City Department of Health and Mental Hygiene as assistant commissioner for the Primary Care Information Project, where he co-led agile development of population health management functionality within a commercial EHR, and its adoption by more than 1,500 providers in underserved communities. Dr. Mostashari also led the NYC Center of Excellence in Public Health Informatics and an Agency for Healthcare Research and Quality-funded project focused on quality measurement at the point of care. Dr. Mostashari conducted graduate training at the Harvard School of Public Health and Yale Medical School, served his internal medicine residency at Massachusetts General Hospital, and completed the CDC s Epidemic Intelligence Service program. He was a lead investigator in the outbreaks of West Nile Virus, and anthrax in New York City and among the first developers of real-time nationwide electronic disease surveillance systems.

17 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. KEYNOTE SPEAKERS Derek Rapp, President and Chief Executive Officer, Juvenile Diabetes Research Foundation (JDRF) Derek Rapp has most recently been the Mergers and Acquisitions Lead for Monsanto Company and previously served 10 years as CEO of Divergence, Inc. a start-up biotechnology company. Mr. Rapp has been involved with JDRF since his son, Turner, was diagnosed with the disease in He has served on the JDRF IBOD since In addition to that role, he has served as Research Chair and as a member of the Research Committee, the Lay Review Committee, the Strategic Alliances Committee, the Development Committee and the Advocacy Committee. His wife, Emily, recently completed a term as Board President for the Greater Missouri/Southern Illinois Chapter of JDRF. Mr. Rapp has been a successful CEO of a biotechnology start-up and recently served as a senior executive of a complicated, global biotechnology business.

18 KEYNOTE SPEAKERS Dan Mendelson, President, Avalere Dan Mendelson serves as President of Avalere Health, a subsidiary of Inovalon. Avalere is a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare system through data-driven advisory services and business intelligence products. As President, Mr. Mendelson leads the organization s focus on bringing data-enabled strategic guidance and tools to the full array of healthcare companies from pharmaceuticals and life sciences, to managed care and providers. Prior to founding Avalere Health, Mr. Mendelson served as Associate Director for Health at the Office of Management and Budget (OMB) in the Clinton White House from 1998 to He was responsible for the full healthcare portfolio including Medicare, Medicaid, the National Institutes of Health (NIH) Centers for Disease Control and Prevention (CDC) and the Federal Drug Administration (FDA). His work included development of the Medicare pharmaceutical benefit, Presidential initiatives in health information technology and medical error prevention, the electronic disease surveillance system, and federal policies in reimbursement and technology assessment. Preceding his position at OMB, Mr. Mendelson was Senior Vice President of The Lewin Group and Director of the Medical Technology Practice. During his eight-year tenure at Lewin, he had a range of responsibilities, including management of a transnational pharmaceutical and medical device consulting practice. Between 1994 and 1996, Mr. Mendelson was also closely involved in the operations of Value Rx, a pharmacy benefit management company (PBM). He also actively assisted both Value Health and Quintiles Transnational in due diligence on acquisitions. Mr. Mendelson presently serves on the Board of Champions Oncology (CSBR) and is Executive in Residence at the Fuqua School of Business at Duke University. He previously served on the boards of Coventry Healthcare (sold to Aetna in 2013), PharMerica Corporation (PMC) and HMS holdings (HMSY). Mr. Mendelson has published widely in peer-reviewed and professional journals on health information technology, the costs of disease, hospital costs and operations, physician payment, the economics of managed care, medical malpractice and a range of other topics. He holds an undergraduate degree in economics and viola performance from Oberlin College and a Masters in Public Policy from the Kennedy School of Government at Harvard University.

19 Inovalon Client Congress 2017 October 1-3 The Ritz-Carlton Washington, D.C. KEYNOTE SPEAKERS Rob Califf, M.D., Former Commissioner, U.S. Food and Drug Administration; Vice Chancellor, Health Data Science, Duke University; Advisor, Verily [formerly Google Life Sciences] Robert M. Califf, MD, MACC, is vice chancellor for health data science and director of the Center for Integrated Health Data Science at Duke Health, the Donald F. Fortin, MD Professor of Cardiology in the Duke University School of Medicine, and an advisor for Verily Life Sciences, a member of the Alphabet family of companies formed by Google. He served in the administration of President Barack Obama as Deputy Commissioner for Medical Products and Tobacco in the U.S. Food and Drug Administration (FDA) from , and as Commissioner of Food and Drugs from Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He was founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with 1,250 publications in the peer-reviewed literature. Dr. Califf is a member of the National Academy of Medicine (formerly the Institute of Medicine [IOM]). Dr. Califf has served on numerous IOM committees and was a member of the FDA Cardiorenal Advisory Panel and FDA Science Board s Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging. He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership cofounded by the FDA and Duke. He also served as the principal investigator for Duke s Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center, and as co-principal investigator of the National Patient-Centered Clinical Research Network (PCORnet). He currently serves as chair of the board of the People-Centered Research Foundation, a not-for-profit organization that is supporting and extending the work of PCORnet. Dr. Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

20 KEYNOTE SPEAKERS Shantanu Agrawal, M.D., President and Chief Executive Officer, National Quality Forum (NQF) Shantanu Agrawal, M.D., is a board-certified emergency medicine physician who has worked in both academic and community settings. Dr. Agrawal is also the former deputy administrator and director for the Centers for Medicare & Medicaid Services (CMS) Center for Program Integrity (CPI). Most recently at CMS, Dr. Agrawal led a new effort to improve the physician experience with Medicare by working to minimize the administrative tasks with which doctors contend. He also was one of the main architects of CMS recently released strategy and action plan to address the national opioid misuse epidemic. His main focus at CPI was improving healthcare value by lowering the cost of care through the detection and prevention of waste, abuse and fraud in the Medicare and Medicaid programs. From 2012 through 2014, CPI s prevention efforts saved Medicare and Medicaid $42 million. Dr. Agrawal previously served as CPI s chief medical officer and was instrumental in launching new initiatives in data transparency and analytics, utilization management, assessment of novel payment models and stewarding a major public-private partnership between CMS and private payers, the Health Care Fraud Prevention Partnership. Prior to joining CMS, Dr. Agrawal was a management consultant at McKinsey & Company, serving the senior management of hospitals, health systems and biotech and pharmaceutical companies on projects to improve the quality and efficiency of healthcare delivery. Dr. Agrawal has also worked for a full-risk, capitated delivery system as its leader for clinical innovation and efficiency.